Roche today announced that Roland Diggelmann, CEO Diagnostics Division and member of the Corporate Executive Committee, will be leaving Roche to pursue his career outside of the company effective 30 September 2018. Until a successor is named, Michael Heuer, currently Region Head Europe, Middle East, Africa, and Latin America for Roche Diagnostics will assume the ad interim leadership of Roche’s Diagnostics Division and become a member of the Corporate Executive Committee.
Evox raises €37m in Series B round
Latest NewsExosome drug delivery specialist Evox Therapeutics Ltd has closed a €37.1m (£35.5m) Series B financing round led by Redmile Group and significant contributions from GV (Google Ventures) and Cowen Healthcare Investments.
New Secretary General & Directors at EuropaBio
AppointmentsEuropaBio today confirmed the appointment of Joanna Dupont-Inglis as its new Secretary General.
Commenting on this promotion, EuropaBio chair, Tjerk de Ruiter, said Joanna has an excellent track record of leadership and engagement in this sector. Her experience will be valuable in working together with an increasingly broad community of stakeholders to ensure that the benefits of biotech can be accessed in Europe”.
Sanofi gets the EU’s ok for caplacizumab
Latest NewsThe EU approved Sanofi’s Cablivi (caplacizumab) as the first antibody therapeutic to treat acquired thrombotic thrombocytopenic purpura (aTTP) on Friday.
Cancer drug cures orphan disease skin damage
Latest NewsAn FDA-approved cancer drug stops light sensitivity of the skin in Cockayne syndrome (CS), an ultra-rare hereditary disease characterised by premature aging, German researchers report.
Germany to pump €1bn into breakthrough innovation
Latest NewsGermany’s government announced that it will create an agency for breakthrough ("jump") innovation to foster technology transfer of risky research projects with high market potential into products.
Urovant Sciences licenses OAB gene therapy
Latest NewsChanges at Roche – Diagnostics CEO to leave
AppointmentsRoche today announced that Roland Diggelmann, CEO Diagnostics Division and member of the Corporate Executive Committee, will be leaving Roche to pursue his career outside of the company effective 30 September 2018. Until a successor is named, Michael Heuer, currently Region Head Europe, Middle East, Africa, and Latin America for Roche Diagnostics will assume the ad interim leadership of Roche’s Diagnostics Division and become a member of the Corporate Executive Committee.
Congenica Appoints Wendy Britten as CFO
AppointmentsCongenica today announced the appointment of Mrs Wendy Britten as its new Chief Financial Officer (CFO), effective 1st September, 2018. Mrs Britten will have overall control and responsibility for all financial aspects of the business and will play a key role in business development and fundraising activities.
Roche and Affimed in US$5bn cancer deal
Latest NewsRoche’s US arm Genentech has licenced Affimed NV’s ROCK platform to add multivalent antibodies, which could activate the innate immune system, to its cancer pipeline.
Foundation launches £30m award
Latest NewsThe British Heart Foundation (BHF) will tender £30m (€33.2m) to tackle the suffering and devastation caused by heart and circulatory diseases.